Search details
1.
Sublethal necroptosis signaling promotes inflammation and liver cancer.
Immunity
; 56(7): 1578-1595.e8, 2023 07 11.
Article
in English
| MEDLINE | ID: mdl-37329888
2.
Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function.
Immunity
; 51(6): 1074-1087.e9, 2019 12 17.
Article
in English
| MEDLINE | ID: mdl-31784108
3.
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension.
Hepatology
; 2024 Mar 06.
Article
in English
| MEDLINE | ID: mdl-38447034
4.
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Hepatology
; 2024 Mar 22.
Article
in English
| MEDLINE | ID: mdl-38506926
5.
Assessment of fatigue and its impact in chronic liver disease.
J Hepatol
; 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38670320
6.
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
J Hepatol
; 80(5): 744-752, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38218352
7.
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
J Hepatol
; 2024 Mar 11.
Article
in English
| MEDLINE | ID: mdl-38479612
8.
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
J Hepatol
; 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38823501
9.
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
Gastroenterology
; 165(4): 1041-1052, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37442301
10.
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
Clin Gastroenterol Hepatol
; 22(2): 283-294.e5, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37716616
11.
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.
Hepatology
; 77(1): 20-32, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35686937
12.
Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating event.
Hepatology
; 78(4): 1149-1158, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37190823
13.
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Hepatology
; 78(1): 195-211, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36924031
14.
Differences between men and women with respect to colorectal cancer mortality despite screening colonoscopy.
Gastrointest Endosc
; 99(6): 998-1005.e2, 2024 06.
Article
in English
| MEDLINE | ID: mdl-38184115
15.
Preexposition Prophylaxis With Truvada (Tenofovir/Emtricitabine) as Potential Cause of Celiac Disease-Like Enteropathy.
Z Gastroenterol
; 62(3): 404-406, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37187186
16.
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Gut
; 72(3): 581-589, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36750244
17.
Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.
J Lipid Res
; 64(9): 100427, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37595802
18.
FXR agonists in NASH treatment.
J Hepatol
; 79(5): 1317-1331, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37562746
19.
Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases.
J Hepatol
; 78(2): 430-441, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36272496
20.
Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Clin Gastroenterol Hepatol
; 21(9): 2318-2326.e7, 2023 08.
Article
in English
| MEDLINE | ID: mdl-35842118